本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

iTeos Therapeutics

10.17
+0.19001.90%
盤後10.170.00000.00%16:44 EDT
成交量:111.47萬
成交額:1,121.43萬
市值:3.89億
市盈率:-3.29
高:10.19
開:10.00
低:9.96
收:9.98
資料載入中...
2025/06/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/05

重要事件披露

Form 8-K - Current report
2025/06/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/28

重要事件披露

Form 8-K - Current report
2025/05/13

重要事件披露

Form 8-K - Current report
2025/04/29

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/03/05

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/05

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/01/13

重要事件披露

Form 8-K - Current report
2024/11/21

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/18

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/18

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]